Active material: meglumin sodium succinate
When ATH: B05BB
CCF: The drug is a detoxification effect for parenteral use
ICD-10 codes (testimony): R54, Z51.8
When CSF: 21.06
Manufacturer: POLYSAN NTFF Ltd. (Russia)
Solution for infusion 1.5% clear, colorless.
| 100 ml | |
| meglumin sodium succinate | 1.5 g |
Excipients: sodium chloride, potassium chloride, magnesium chloride, Sodium hydroxide, water d / and.
100 мл – бутылки (1) – пачки картонные.
200 мл – бутылки (1) – пачки картонные.
400 мл – бутылки (1) – пачки картонные.
The drug is a detoxification effect for parenteral use. It has anti-inflammatory and antioxidant action, exerting a positive effect on aerobic processes in the cell, reducing the production of free radicals and restoring the energy potential of the cells.
The drug activates enzymatic processes the Krebs cycle and promotes utilization of fatty acids and glucose into cells, normalizes acid-base balance and blood gases. It has a mild diuretic effect.
The on / in the introduction of the drug can be utilized in quickly and does not accumulate in the body.
- As a means of detoxification and antihypoxic acute endogenous and exogenous intoxications of different etiology in adults and children older 1 g.
Adults Reamʙerin® introduced into / in the drip at a rate of no more than 90 drop / min. (1-4.5 ml / min) in volume 400-800 ml / day.
The rate of administration and dosage is determined according to the degree of severity of the disease of the patient.
Children under the age of 1 year Reamʙerin® injected / drip rate of 6-10 ml / kg body weight 1 times / day with a velocity 3-4 ml / min. The daily dose should not exceed 400 ml.
Course duration of administration should not exceed 11 days.
Maybe: the rapid introduction of the drug momentary feeling the heat, reddening of the upper body.
- State after traumatic brain injury, accompanied by a swelling of the brain;
- Expressed by the human kidney;
- Pregnancy;
- Lactation (breast-feeding);
- Hypersensitivity to the drug.
FROM caution drug should be used during alkalosis.
The drug is contraindicated during pregnancy and lactation.
Against the background of Reamberin® may cause an alkaline reaction of blood and urine (because activation aerobic processes in the body).
Data on drug overdose Reamberin® not provided.
The drug can be used in combination with antibiotics, water-soluble vitamins and glucose solution.
The drug is released under the prescription.
The drug should be stored out of reach of children, dark place at a temperature from 0 ° to 25 ° C; Avoid freezing. Shelf life - 5 years.
If you change the color of the solution or the presence of sediment drug application inadmissible.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More